End stage liver disease Flashcards
What might you find in a patient with compensated liver cirrhosis?
evidence of liver damage like nodular liver but no change in the function of the liver, less likely to see signs of portal HTN
Describe the syndrome of decompensated cirrhosis (= end stage liver disease)
hepatocellular dysfunction, often complications of portal HTN including:
jaundice, cholestasis, fat soluble vitamin deficiency, coagulopathy (mucosal bleeding, bruising), hepatic encephalopathy, hypoalbulinemia, changes in hormonal levels
What are the complications portal hypertension?
ascites, spontaneous bacterial peritonitis, hepatorenal syndrome, vatical hemorrhage, hepatic encephalopathy, pulmonary complications (hepatic hydrothorax, portopulmonary HTN
What are the two main contributors to increasing portal HTN?
increased resistance due to fibrosis and splanchnic vasodialtion causing increased portal flow
List causes of pre sinusoidal, sinusoidal and post sinusoidal portal HTN.
pre: portal vein occlusion, splenic vein occlusion, schistosomiasis
sinusoidal: cirrhosis
post: pericardial constriction, IVC occlusion (Budd Chiari), vent occlusive disease
What qualities of a vatical hemorrhage make it a risk to bleed?
portal pressure gradient >10-12mmHg
large vary, with surface marks (red wales)
decompensated liver
(based on LaPlace’s Law taking into account wall tension, pressure difference, radius, wall thickness )
What are methods to treat acute vatical hemorrhage?
early endoscopy: with vatical band ligation, gastric glue possible, sclerosing agents
reduce pressure gradient by portosystemic shunts with meds (octreotide, vasopressin) or chronically with TIPS
What are ways to assess the portal pressure?
direct measurement of hepatic venous pressure gradient
indirect indicators include portosystemic collaterals, splenomegaly, thrombocytopenia
Chronic portal HTN causes initiation of what cascade of events?
portal HTN, endogenous vasodilators (NO, glucagon, endocannibanoids) leads to splanchnic and peripheral vasodilation
splanchnic dilation leads to decreased arterial pressure, decreased SVR and increased HR to maintain CO and ultimately ineffective arterial filling
ineffective arterial filling (decreased effective circulating volume-like) leads to stimulation of RAAS, SNS and ADH causing sodium and water retention, renal vasoconstriction and hepatorenal syndrome
T/F Ascites is due to portal HTN.
sometimes but not always true, can be due to other causes
How would you determine if ascites is due to portal HTN or non-portal HTN causes? How do you calculate SAAG
Portal HTN: SAAG> 1.1
Non-portal HTN: <1.1 (malignancy, infection, pancreatic/biliary leaks
calculate SAAG= (serum albumin- ascites)
Serum-ascites albumin gradient
Describe treatments available for ascites therapy.
salt restriction diet
diuretics (aldosterone antagonists and loop diuretics)
paracentesis (when removing large amounts add albumin)
portosystemic shunt
liver transplantation
What is spontaneous bacterial peritonitis and how is it dx?
usually occurring in those with cirrhosis (causes the ascites) and then is infected with colonic bacteria, commonly E. coli, K pneumonia and S. pneumonia; if patient has poor hepatic reserve there is a poor prognosis
dx: with parencentesis > 250 PMN per mm3, although there is no organism found in 30-50% of people
tx. antibiotics and albumin
What is Hepato-renal syndrome?
renal failure failure occur in cirrhosis which the kidney acts as if the patient were in shock (portal HTN is a key factor)- poor prognosis
asscociated with splachnic/peripheral vasodilation and internal vasoconstriction and retention of sodium
How might you treat hepatorenal syndrome?
maintain intravascular volume and avoid nephrotoxins (NSAIDs)
octreotide, midodrine and albumin may help to reduce the portal HTN and ascites
occasionally transjugular intravascular portosystemic shunt or liver transplantation may be use